Sale!

SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SPTA1 gene responsible for hereditary spherocytosis type 3. This comprehensive genetic analysis utilizes next-generation sequencing technology to detect specific genetic variations that cause abnormal red blood cell morphology and hemolytic anemia. The test provides crucial information for accurate diagnosis, treatment planning, and family genetic counseling. Patients experiencing symptoms such as jaundice, anemia, fatigue, or splenomegaly should consider this test. At only $500 USD, this advanced genetic screening offers definitive answers for hereditary blood disorders and enables informed healthcare decisions for affected individuals and their families.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Spherocytosis

The SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for hereditary hemolytic anemias. This advanced genetic screening utilizes next-generation sequencing (NGS) technology to identify specific mutations in the SPTA1 gene, which encodes the alpha-spectrin protein crucial for maintaining red blood cell membrane integrity and structural stability.

What This Test Measures and Detects

This sophisticated genetic analysis specifically targets and sequences the entire SPTA1 gene to identify pathogenic variants responsible for hereditary spherocytosis type 3. The test detects:

  • Point mutations, insertions, and deletions in the SPTA1 gene
  • Autosomal recessive inheritance patterns
  • Specific genetic variants affecting spectrin protein production
  • Mutations leading to defective red blood cell membrane structure
  • Genetic markers associated with varying disease severity

Who Should Consider This Genetic Test

This comprehensive genetic screening is recommended for individuals presenting with:

  • Unexplained hemolytic anemia symptoms
  • Chronic jaundice or elevated bilirubin levels
  • Family history of hereditary spherocytosis
  • Recurrent gallstones at a young age
  • Splenomegaly (enlarged spleen) without clear cause
  • Abnormal red blood cell morphology on peripheral smear
  • Positive osmotic fragility test results
  • Planning for pregnancy with family history of blood disorders

Significant Benefits of Genetic Testing

Undergoing the SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test provides numerous advantages:

  • Definitive Diagnosis: Confirms hereditary spherocytosis type 3 with molecular precision
  • Family Planning Guidance: Enables informed reproductive decisions and genetic counseling
  • Personalized Treatment: Guides appropriate therapeutic interventions and monitoring
  • Prognostic Information: Helps predict disease severity and progression
  • Early Intervention: Facilitates timely management of complications
  • Genetic Counseling: Provides comprehensive family risk assessment

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our certified genetic counselors:

  • Positive Result: Indicates the presence of SPTA1 gene mutations confirming hereditary spherocytosis type 3 diagnosis
  • Negative Result: Suggests absence of detectable SPTA1 mutations, though clinical correlation is essential
  • Variant of Uncertain Significance: Requires additional family studies and clinical evaluation
  • Carrier Status: Identifies individuals with single gene copy mutations who may pass the condition to offspring

Test Pricing and Details

Test Feature Details
Test Name SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your genetic test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Understanding of potential outcomes and their significance

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about hereditary blood disorders affect your quality of life. The SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of hematology genetics specialists and certified genetic counselors are ready to guide you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive answers about your hereditary health.

Book your SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test now and receive comprehensive genetic insights with our advanced next-generation sequencing technology. Our dedicated team ensures confidential, accurate, and timely results to support your healthcare journey.